Immunoblot analysis revealed that the pro-apoptotic markers BAX and cleaved caspase-3 were increased and the anti-apoptotic marker BCL-2 was decreased in BMAL1-overexpressing glioblastoma cells compared with control cells (Figure 5). The gene discussed is BCL2; the disease is glioblastoma.